MatsukiyoCocokaraMSMKF 84 Return-on-Tangible-Asset is 8.49% as of Mar. 2026, which is 6% above its 10-year median of 7.98. GuruFocus rates MSMKF with a GF Score™ of 84/100 and a GF Value™ of $20.74 (Modestly Undervalued). Among 682 Healthcare Providers & Services companies, MatsukiyoCocokara ranks better than 78.74% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. MatsukiyoCocokara's annualizedNet Income for the quarter that ended in Mar. 2026 was $332 Mil. MatsukiyoCocokara's average total tangible assets for the quarter that ended in Mar. 2026 was $3,915 Mil. Therefore, MatsukiyoCocokara's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 8.49%.
The historical rank and industry rank for MatsukiyoCocokara's Return-on-Tangible-Asset or its related term are showing as below:
MSMKF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.15 Med: 7.98 Max: 9.37
Current: 9.37
During the past 13 years, MatsukiyoCocokara's highest Return-on-Tangible-Asset was 9.37%. The lowest was 6.15%. And the median was 7.98%.
MSMKF's Return-on-Tangible-Asset is ranked better than 78.74% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs MSMKF: 9.37
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
MatsukiyoCocokara Return-on-Tangible-Asset Related Terms
MatsukiyoCocokara Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for MatsukiyoCocokara's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, MatsukiyoCocokara's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MatsukiyoCocokara Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MatsukiyoCocokara's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where MatsukiyoCocokara's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 8.49% mean?
MatsukiyoCocokara (MSMKF) has a Return-on-Tangible-Asset of 8.49% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on MatsukiyoCocokara and its competitors. This is near median its historical median of 7.98. Over the past decade, MatsukiyoCocokara's Return-on-Tangible-Asset has ranged from 6.15 to 9.37. According to the industry distribution chart, MatsukiyoCocokara ranks #145 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 21.3%.
Is MatsukiyoCocokara's Return-on-Tangible-Asset too high?
MatsukiyoCocokara's current Return-on-Tangible-Asset of 8.49% is near median its 10-year median of 7.98. Over the past 10 years, this metric has ranged from a low of 6.15 to a high of 9.37. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. MatsukiyoCocokara's value of 8.49% is 244.4% above this industry median. Based on the distribution chart, MatsukiyoCocokara ranks #145 out of 682 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MatsukiyoCocokara has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MatsukiyoCocokara's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, MatsukiyoCocokara ranks #145 out of 682 companies for Return-on-Tangible-Asset. This places MatsukiyoCocokara in the top 21% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 2.47. MatsukiyoCocokara's value of 8.49% is 244.4% above this benchmark. Historically, MatsukiyoCocokara's own Return-on-Tangible-Asset has ranged from 6.15 to 9.37 over the past decade. While the company's 10-year median is 7.98 vs. the industry median of 2.47, MatsukiyoCocokara has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MatsukiyoCocokara's current Return-on-Tangible-Asset of 8.49% is 244.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on MatsukiyoCocokara and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MatsukiyoCocokara's current Return-on-Tangible-Asset is 8.49%, which is near median its own 10-year median of 7.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MatsukiyoCocokara stock overvalued right now?
Based on GuruFocus' analysis, MatsukiyoCocokara (MSMKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.74, compared to a current price of $14.88 — trading 28.3% below its estimated fair value. The current Return-on-Tangible-Asset is 8.49%, which is near median its 10-year median of 7.98 and 244.4% above the Healthcare Providers & Services industry median of 2.47. MatsukiyoCocokara's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For MatsukiyoCocokara (MSMKF), the current Return-on-Tangible-Asset is 8.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MatsukiyoCocokara (MSMKF) Overvalued in 2026?
Based on GuruFocus' analysis, MatsukiyoCocokara stock appears to be undervalued.
The current stock price of $14.88 is trading 28.3% below its estimated GF Value™ of $20.74.
GuruFocus considers MatsukiyoCocokara to be Modestly Undervalued.
Key valuation signals for MSMKF:
Return-on-Tangible-Asset: 8.49% (near median its 10-year median of 7.98)
GF Value™: $20.74 vs. price of $14.88 (28.3% below fair value)
Industry Position: 244.4% above the Healthcare Providers & Services median (#145 of 682)
No single metric tells the full story. See the MSMKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MatsukiyoCocokara & Co operates retail drugstores and insurance dispensing pharmacies in Japan. The company's main segments are the Matsumotokiyoshi Group Business, focused on stores under the Matsumotokiyoshi brand; the Cocokara Fine Group Business, centered on Cocokara Fine stores; and the Management Support Business, which procures products, oversees group operations, and manages indirect functions such as advertising and promotion. It generates the majority of its revenue from the Matsumotokiyoshi Group Business segment.
84GF Score
Get the complete analysis for MSMKF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MSMKF has been successfully added to your 
